Today, Heron Therapeutics Inc Inc’s (NASDAQ: HRTX) stock fell $0.1, accounting for a 0.94% decrease. Heron opened at $10.82 before trading between $10.82 and $10.48 throughout Friday’s session. The activity saw Heron’s market cap fall to $1,079,221,499 on 742,616 shares -below their 30-day average of 1,385,478.
About Heron Therapeutics Inc
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.